The invention provides a new class of antibiotics to which pathogenic
bacteria have not been exposed, and thus should not have developed
resistance. This new class of antibiotics are derivatives of
.beta.-cyclodextrin (.beta.-CD), which is a cyclic molecule comprising
seven D-glucose units.